trending Market Intelligence /marketintelligence/en/news-insights/trending/dzvmlbTlbYSKQ-IB6y205g2 content esgSubNav
In This List

Novelion Therapeutics appoints CFO

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Blog

Insight Weekly: PE firms shift strategies; bank earnings kick off; bankruptcies plummet

Blog

Insight Weekly: Stocks limp into 2023; GCC banks set for rebound; deep-sea mining faces pushback

Blog

Infographic: The Big Picture 2023 Issuer & Investor Relations Outlook


Novelion Therapeutics appoints CFO

Novelion Therapeutics Inc. appointed Michael Price as CFO and senior vice president, effective Dec. 4.

Price joins Novelion from Noven Pharmaceuticals Inc., where he served as vice president and CFO.

Gregory Perry has resigned as CFO of Novelion to pursue other opportunities, and will remain with the company until Dec. 31 to enable an effective transition.